Compile Data Set for Download or QSAR
Report error Found 70 Enz. Inhib. hit(s) with all data for entry = 11902
TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658675BDBM658675(Sodium 5-bromobenzo[h]isoquinoline-8- carboxylate ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658709BDBM658709(Sodium 1-amino-6-bromobenzo[h]isoquinoline-8- carb...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658676BDBM658676(Sodium benzo[h]isoquinoline-8-carboxylate | US1193...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658675BDBM658675(Sodium 5-bromobenzo[h]isoquinoline-8- carboxylate ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658678BDBM658678(US11932606, Compound 4 | Sodium 5-((3- chloropheny...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658677BDBM658677(Sodium 5-chlorobenzo[h]isoquinoline-8-carboxylate ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658678BDBM658678(US11932606, Compound 4 | Sodium 5-((3- chloropheny...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658699BDBM658699(Sodium 1-chlorobenzo[h]isoquinoline-8-carboxylate ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658700BDBM658700(Sodium 5-nitrobenzo[h]isoquinoline-8-carboxylate |...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658697BDBM658697(Sodium 5-bromo-1-chlorobenzo[h]isoquinoline-8- car...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658703BDBM658703(Sodium 1-amino-5-bromobenzo[h]isoquinoline-8- carb...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658701BDBM658701(Sodium 5-cyanobenzo[h]isoquinoline-8-carboxylate |...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658703BDBM658703(Sodium 1-amino-5-bromobenzo[h]isoquinoline-8- carb...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658702BDBM658702(Sodium 5-cyclopropylbenzo[h]isoquinoline-8- carbox...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658691BDBM658691(Sodium 5-(cyclopropylamino)benzo[h]isoquinoline- 8...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658692BDBM658692(Sodium 5-(cyclobutylamino)benzo[h]isoquinoline-8- ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658689BDBM658689(Sodium 5-(cyclopentylamino)benzo[h]isoquinoline- 8...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658691BDBM658691(Sodium 5-(cyclopropylamino)benzo[h]isoquinoline- 8...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658690BDBM658690(Sodium 5-(sec-butylamino)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658696BDBM658696(Sodium (R)-5-(sec- butylamino)benzo[h]isoquinoline...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658695BDBM658695(Sodium 5-(isopropylamino)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658696BDBM658696(Sodium (R)-5-(sec- butylamino)benzo[h]isoquinoline...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658693BDBM658693((S)-5-(sec-butylamino)benzo[h]isoquinoline-8- carb...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658694BDBM658694(Sodium 5-(piperidin-1-yl)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658683BDBM658683(Sodium 5-methylbenzo[h]isoquinoline-8- carboxylate...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658684BDBM658684(Sodium 5-(6-aminopyridin-3- yl)benzo[h]isoquinolin...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658681BDBM658681(Sodium 5-(pyridin-3-yl)benzo[h]isoquinoline-8- car...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658682BDBM658682(Sodium 5-(pyridin-4-yl)benzo[h]isoquinoline-8- car...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658688BDBM658688((R)-5-(3-aminopiperidin-1-yl)benzo[h]isoquinoline-...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658685BDBM658685(Sodium 5-(1H-pyrazol-3-yl)benzo[h]isoquinoline-8- ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658686BDBM658686(Sodium 5-(cyclohexylamino)benzo[h]isoquinoline- 8-...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658692BDBM658692(Sodium 5-(cyclobutylamino)benzo[h]isoquinoline-8- ...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658677BDBM658677(Sodium 5-chlorobenzo[h]isoquinoline-8-carboxylate ...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658708BDBM658708(Sodium 5-bromo-1-methoxybenzo[h]isoquinoline-8- ca...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658690BDBM658690(Sodium 5-(sec-butylamino)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658707BDBM658707(1-Amino-5-bromobenzo[h]isoquinoline-8- carboxamide...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658706BDBM658706(Sodium 5-bromo-1- (methylamino)benzo[h]isoquinolin...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658697BDBM658697(Sodium 5-bromo-1-chlorobenzo[h]isoquinoline-8- car...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658680BDBM658680(Sodium 5-(4-chlorophenyl)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658678BDBM658678(US11932606, Compound 4 | Sodium 5-((3- chloropheny...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658694BDBM658694(Sodium 5-(piperidin-1-yl)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658709BDBM658709(Sodium 1-amino-6-bromobenzo[h]isoquinoline-8- carb...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658678BDBM658678(US11932606, Compound 4 | Sodium 5-((3- chloropheny...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658695BDBM658695(Sodium 5-(isopropylamino)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658700BDBM658700(Sodium 5-nitrobenzo[h]isoquinoline-8-carboxylate |...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658684BDBM658684(Sodium 5-(6-aminopyridin-3- yl)benzo[h]isoquinolin...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658701BDBM658701(Sodium 5-cyanobenzo[h]isoquinoline-8-carboxylate |...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658683BDBM658683(Sodium 5-methylbenzo[h]isoquinoline-8- carboxylate...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658689BDBM658689(Sodium 5-(cyclopentylamino)benzo[h]isoquinoline- 8...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandChemical structure of BindingDB Monomer ID 658702BDBM658702(Sodium 5-cyclopropylbenzo[h]isoquinoline-8- carbox...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
US Patent

Displayed 1 to 50 (of 70 total ) | Next | Last >>
Jump to: